Lilly to acquire Orna Therapeutics to advance cell therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. PATH
5. DOCU
6. SPY
7. ASAN
8. GWRE
9. CIEN
10. CPB

Go back to Lilly to acquire Orna Therapeutics to advance cell therapies
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1143.53 -16.07 (1.39%)
Previous Close $1159.60    52 Week High $88.16 
Open $1150.61    52 Week Low $67.88 
Day High $1158.44    P/E 264.71 
Day Low $1141.60    EPS $4.32 
Volume 572,225